Optune® is a noninvasive device to treat newly-diagnosed and recurrent Glioblastoma (GBM) Tumors. The device is a wearable, portable, FDA-approved device indicated to treat GBM tumors in adult patients 22 years of age or older.
If you have newly diagnosed GBM, Optune is used together with a chemotherapy called temozolomide (TMZ) if:
If your tumor has come back, Optune can be used alone as an alternative to standard medical therapy if:
Optune works by delivering low-intensity, wave-like electric fields to the location of the GBM tumor. These electric fields interfere with GBM tumor cell division, which may slow down or stop cell division and may cause the cells to be destroyed.
If you would like more information about Optune, please visit their official website.
Optune is not for everyone. You may not be a candidate for Optune if you have:
Do not use Optune if you are pregnant or are planning to become pregnant. It is not known if Optune is safe or effective during pregnancy.